SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,536,000 | -63.0% | 18,072 | -67.9% | 0.01% | -70.8% |
| Q2 2020 | $9,566,000 | +168.3% | 56,296 | +82.2% | 0.05% | +108.7% |
| Q1 2020 | $3,566,000 | +72.4% | 30,904 | +70.7% | 0.02% | +228.6% |
| Q4 2019 | $2,069,000 | +404.6% | 18,106 | +205.6% | 0.01% | +600.0% |
| Q2 2019 | $410,000 | -47.2% | 5,924 | -44.1% | 0.00% | -66.7% |
| Q1 2019 | $776,000 | +98.0% | 10,589 | +53.1% | 0.00% | +50.0% |
| Q4 2018 | $392,000 | -69.8% | 6,917 | -58.9% | 0.00% | -60.0% |
| Q3 2018 | $1,296,000 | +130.2% | 16,814 | +98.4% | 0.01% | +150.0% |
| Q2 2018 | $563,000 | -19.9% | 8,476 | -36.9% | 0.00% | -33.3% |
| Q1 2018 | $703,000 | – | 13,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |